1992
DOI: 10.3109/03602539208996298
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Aspects of Paracetamol-Induced Hepatotoxicity and its Mechanism-Based Prevention

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

8
186
0
2

Year Published

1996
1996
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 286 publications
(196 citation statements)
references
References 106 publications
8
186
0
2
Order By: Relevance
“…Despite considerable research, the mechanisms responsible for acetaminophen (APAP) hepatotoxicity in humans and experimental animals are not yet fully understood (for reviews see Nelson, 1 Vermeulen et al, 2 Hinson et al, 3 and Cohen et al 4 ). Metabolic activation 5 of APAP and subsequent binding of its electrophilic metabolite N-acetyl-p-benzoquinone imine (NAPQI) to glutathione (GSH) and, after GSH depletion, to nucleophilic protein targets 6 seems to be necessary but is not sufficient for toxicity.…”
mentioning
confidence: 99%
“…Despite considerable research, the mechanisms responsible for acetaminophen (APAP) hepatotoxicity in humans and experimental animals are not yet fully understood (for reviews see Nelson, 1 Vermeulen et al, 2 Hinson et al, 3 and Cohen et al 4 ). Metabolic activation 5 of APAP and subsequent binding of its electrophilic metabolite N-acetyl-p-benzoquinone imine (NAPQI) to glutathione (GSH) and, after GSH depletion, to nucleophilic protein targets 6 seems to be necessary but is not sufficient for toxicity.…”
mentioning
confidence: 99%
“…The hepatotoxicity of Paracetamol ® is as a result of formation of toxic metabolites when part of it is activated by hepatic . cytochrome p-450 to a highly reactive metabolite-N-acetyl-pbenzoquinonimine (NAPQI) [3,4]. Liver disorders are global problem.…”
Section: Introductionmentioning
confidence: 99%
“…When consumed in large doses, it is known to cause severe centrilobular hepatic toxicity [1][2][3]. But at therapeutic doses is rapidly metabolized in the liver principally through glucuronidation and sulfation, and only a small portion is oxidized by cytochrome P-450 2E1 to generate a highly reactive and cytotoxic intermediate, N-acetyl-p-benzoquinoneimine (NAPQI) [4,5]. This metabolite is efficiently detoxified by being reduced back to APAP or covalently linked to GSH to form a 3-glutathione-S-yl-APAP conjugate [6].…”
Section: Introductionmentioning
confidence: 99%